CUV 6.88% $13.67 clinuvel pharmaceuticals limited

Ann: CLINUVEL initiates on market share buy-back program, page-31

  1. 742 Posts.
    lightbulb Created with Sketch. 206
    Well the initial response was good. Didn‘t expect the selloff but unless you‘re in the space or know?? Initial short shock and a reposition? Limits on % gains under the buy back won‘t help due to the liquidity - probably easier to run a daily algorithm? Depend on CUV‘s volume buys to see what is countered but still a timely strategy IMO. May not be a raging success unless CUV does have those material announcements on the way.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.